世界の抗菌ペプチド市場予測 2020年-2025年

【英語タイトル】Global Antimicrobial Peptides Market Growth 2020-2025

LP Informationが出版した調査資料(LPI20AP5947)・商品コード:LPI20AP5947
・発行会社(調査会社):LP Information
・発行日:2020年3月27日(※2024年版があります。お問い合わせください)
・ページ数:158
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
「抗菌ペプチドの世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、植物抗菌ペプチド、細菌抗菌ペプチド、動物抗菌ペプチドなど、用途別には、医薬品、飼料添加物、その他などに区分してまとめた調査レポートです。抗菌ペプチドのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・抗菌ペプチドの世界市場概要(サマリー)
・抗菌ペプチドの企業別販売量・売上
・抗菌ペプチドの企業別市場シェア
・抗菌ペプチドの世界市場規模 2015年-2020年:種類別(植物抗菌ペプチド、細菌抗菌ペプチド、動物抗菌ペプチド)
・抗菌ペプチドの世界市場規模 2015年-2020年:用途別(医薬品、飼料添加物、その他)
・抗菌ペプチドの米州市場規模(アメリカ、カナダ、メキシコなど)
・抗菌ペプチドのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・抗菌ペプチドの欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・抗菌ペプチドの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・抗菌ペプチド市場の成長要因・課題・動向
・抗菌ペプチドの世界市場予測 2021年-2025年
・抗菌ペプチドの米州市場予測(アメリカ、カナダ、メキシコなど)
・抗菌ペプチドのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・抗菌ペプチドの欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・抗菌ペプチドの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・抗菌ペプチドの世界市場予測:種類別(植物抗菌ペプチド、細菌抗菌ペプチド、動物抗菌ペプチド)
・抗菌ペプチドの世界市場予測:用途別(医薬品、飼料添加物、その他)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Antimicrobial Peptides market will register a 5.2% CAGR in terms of revenue, the global market size will reach $ 5 million by 2025, from $ 4 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Antimicrobial Peptides business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Antimicrobial Peptides market by type, application, key manufacturers and key regions and countries.

This study considers the Antimicrobial Peptides value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Plant Antimicrobial Peptides
Bacterial Antimicrobial Peptides
Animal Antimicrobial Peptides
Animal antimicrobial peptides hold a comparatively larger share in global market, which accounts for about 60% in 2018.

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Pharmaceuticals
Feed Additives
Others
Pharmaceuticals is the most common application of antimicrobial peptides, which took up more than 86% of the clients in 2018.

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AnaSpec
Ruixing Biotechnology
AMP Biotech
Novabiotics
Chinese Peptide
Phoenix Biotech
Hycult Biotech
Ontores
Sunsmile
GenScript
Zhongnong Yingtai Biotechnology
Glam Technology

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Antimicrobial Peptides consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Antimicrobial Peptides market by identifying its various subsegments.
Focuses on the key global Antimicrobial Peptides manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Antimicrobial Peptides with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Antimicrobial Peptides submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antimicrobial Peptides Consumption 2015-2025
2.1.2 Antimicrobial Peptides Consumption CAGR by Region
2.2 Antimicrobial Peptides Segment by Type
2.2.1 Plant Antimicrobial Peptides
2.2.2 Bacterial Antimicrobial Peptides
2.2.3 Animal Antimicrobial Peptides
2.3 Antimicrobial Peptides Consumption by Type
2.3.1 Global Antimicrobial Peptides Consumption Market Share by Type (2015-2020)
2.3.2 Global Antimicrobial Peptides Revenue and Market Share by Type (2015-2020)
2.3.3 Global Antimicrobial Peptides Sale Price by Type (2015-2020)
2.4 Antimicrobial Peptides Segment by Application
2.4.1 Pharmaceuticals
2.4.2 Feed Additives
2.4.3 Others
2.5 Antimicrobial Peptides Consumption by Application
2.5.1 Global Antimicrobial Peptides Consumption Market Share by Type (2015-2020)
2.5.2 Global Antimicrobial Peptides Value and Market Share by Type (2015-2020)
2.5.3 Global Antimicrobial Peptides Sale Price by Type (2015-2020)

3 Global Antimicrobial Peptides by Company
3.1 Global Antimicrobial Peptides Sales Market Share by Company
3.1.1 Global Antimicrobial Peptides Sales by Company (2018-2020)
3.1.2 Global Antimicrobial Peptides Sales Market Share by Company (2018-2020)
3.2 Global Antimicrobial Peptides Revenue Market Share by Company
3.2.1 Global Antimicrobial Peptides Revenue by Company (2018-2020)
3.2.2 Global Antimicrobial Peptides Revenue Market Share by Company (2018-2020)
3.3 Global Antimicrobial Peptides Sale Price by Company
3.4 Global Antimicrobial Peptides Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Antimicrobial Peptides Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Antimicrobial Peptides Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Antimicrobial Peptides by Regions
4.1 Antimicrobial Peptides by Regions
4.2 Americas Antimicrobial Peptides Consumption Growth
4.3 APAC Antimicrobial Peptides Consumption Growth
4.4 Europe Antimicrobial Peptides Consumption Growth
4.5 Middle East & Africa Antimicrobial Peptides Consumption Growth

5 Americas
5.1 Americas Antimicrobial Peptides Consumption by Countries
5.1.1 Americas Antimicrobial Peptides Consumption by Countries (2015-2020)
5.1.2 Americas Antimicrobial Peptides Value by Countries (2015-2020)
5.2 Americas Antimicrobial Peptides Consumption by Type
5.3 Americas Antimicrobial Peptides Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Antimicrobial Peptides Consumption by Regions
6.1.1 APAC Antimicrobial Peptides Consumption by Regions (2015-2020)
6.1.2 APAC Antimicrobial Peptides Value by Regions (2015-2020)
6.2 APAC Antimicrobial Peptides Consumption by Type
6.3 APAC Antimicrobial Peptides Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Antimicrobial Peptides by Countries
7.1.1 Europe Antimicrobial Peptides Consumption by Countries (2015-2020)
7.1.2 Europe Antimicrobial Peptides Value by Countries (2015-2020)
7.2 Europe Antimicrobial Peptides Consumption by Type
7.3 Europe Antimicrobial Peptides Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Antimicrobial Peptides by Countries
8.1.1 Middle East & Africa Antimicrobial Peptides Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Antimicrobial Peptides Value by Countries (2015-2020)
8.2 Middle East & Africa Antimicrobial Peptides Consumption by Type
8.3 Middle East & Africa Antimicrobial Peptides Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Antimicrobial Peptides Distributors
10.3 Antimicrobial Peptides Customer

11 Global Antimicrobial Peptides Market Forecast
11.1 Global Antimicrobial Peptides Consumption Forecast (2021-2025)
11.2 Global Antimicrobial Peptides Forecast by Regions
11.2.1 Global Antimicrobial Peptides Forecast by Regions (2021-2025)
11.2.2 Global Antimicrobial Peptides Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Antimicrobial Peptides Forecast by Type
11.8 Global Antimicrobial Peptides Forecast by Application

12 Key Players Analysis
12.1 AnaSpec
12.1.1 Company Information
12.1.2 Antimicrobial Peptides Product Offered
12.1.3 AnaSpec Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 AnaSpec Latest Developments
12.2 Ruixing Biotechnology
12.2.1 Company Information
12.2.2 Antimicrobial Peptides Product Offered
12.2.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Ruixing Biotechnology Latest Developments
12.3 AMP Biotech
12.3.1 Company Information
12.3.2 Antimicrobial Peptides Product Offered
12.3.3 AMP Biotech Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 AMP Biotech Latest Developments
12.4 Novabiotics
12.4.1 Company Information
12.4.2 Antimicrobial Peptides Product Offered
12.4.3 Novabiotics Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Novabiotics Latest Developments
12.5 Chinese Peptide
12.5.1 Company Information
12.5.2 Antimicrobial Peptides Product Offered
12.5.3 Chinese Peptide Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Chinese Peptide Latest Developments
12.6 Phoenix Biotech
12.6.1 Company Information
12.6.2 Antimicrobial Peptides Product Offered
12.6.3 Phoenix Biotech Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Phoenix Biotech Latest Developments
12.7 Hycult Biotech
12.7.1 Company Information
12.7.2 Antimicrobial Peptides Product Offered
12.7.3 Hycult Biotech Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Hycult Biotech Latest Developments
12.8 Ontores
12.8.1 Company Information
12.8.2 Antimicrobial Peptides Product Offered
12.8.3 Ontores Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Ontores Latest Developments
12.9 Sunsmile
12.9.1 Company Information
12.9.2 Antimicrobial Peptides Product Offered
12.9.3 Sunsmile Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Sunsmile Latest Developments
12.10 GenScript
12.10.1 Company Information
12.10.2 Antimicrobial Peptides Product Offered
12.10.3 GenScript Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 GenScript Latest Developments
12.11 Zhongnong Yingtai Biotechnology
12.11.1 Company Information
12.11.2 Antimicrobial Peptides Product Offered
12.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Zhongnong Yingtai Biotechnology Latest Developments
12.12 Glam Technology
12.12.1 Company Information
12.12.2 Antimicrobial Peptides Product Offered
12.12.3 Glam Technology Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Glam Technology Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Antimicrobial Peptides Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Plant Antimicrobial Peptides
Table 5. Major Players of Bacterial Antimicrobial Peptides
Table 6. Major Players of Animal Antimicrobial Peptides
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Antimicrobial Peptides Consumption Market Share by Type (2015-2020)
Table 9. Global Antimicrobial Peptides Revenue by Type (2015-2020) ($ million)
Table 10. Global Antimicrobial Peptides Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Antimicrobial Peptides Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Antimicrobial Peptides Consumption Market Share by Application (2015-2020)
Table 14. Global Antimicrobial Peptides Value by Application (2015-2020)
Table 15. Global Antimicrobial Peptides Value Market Share by Application (2015-2020)
Table 16. Global Antimicrobial Peptides Sale Price by Application (2015-2020)
Table 17. Global Antimicrobial Peptides Sales by Company (2017-2019) (Mg)
Table 18. Global Antimicrobial Peptides Sales Market Share by Company (2017-2019)
Table 19. Global Antimicrobial Peptides Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Antimicrobial Peptides Revenue Market Share by Company (2017-2019)
Table 21. Global Antimicrobial Peptides Sale Price by Company (2017-2019)
Table 22. Global Antimicrobial Peptides Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Antimicrobial Peptides Products Offered
Table 24. Antimicrobial Peptides Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Antimicrobial Peptides Consumption by Regions 2015-2020 (Mg)
Table 26. Global Antimicrobial Peptides Consumption Market Share by Regions 2015-2020
Table 27. Global Antimicrobial Peptides Value by Regions 2015-2020 ($ Millions)
Table 28. Global Antimicrobial Peptides Value Market Share by Regions 2015-2020
Table 29. Americas Antimicrobial Peptides Consumption by Countries (2015-2020) (Mg)
Table 30. Americas Antimicrobial Peptides Consumption Market Share by Countries (2015-2020)
Table 31. Americas Antimicrobial Peptides Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Antimicrobial Peptides Value Market Share by Countries (2015-2020)
Table 33. Americas Antimicrobial Peptides Consumption by Type (2015-2020) (Mg)
Table 34. Americas Antimicrobial Peptides Consumption Market Share by Type (2015-2020)
Table 35. Americas Antimicrobial Peptides Consumption by Application (2015-2020) (Mg)
Table 36. Americas Antimicrobial Peptides Consumption Market Share by Application (2015-2020)
Table 37. APAC Antimicrobial Peptides Consumption by Countries (2015-2020) (Mg)
Table 38. APAC Antimicrobial Peptides Consumption Market Share by Countries (2015-2020)
Table 39. APAC Antimicrobial Peptides Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Antimicrobial Peptides Value Market Share by Regions (2015-2020)
Table 41. APAC Antimicrobial Peptides Consumption by Type (2015-2020) (Mg)
Table 42. APAC Antimicrobial Peptides Consumption Market Share by Type (2015-2020)
Table 43. APAC Antimicrobial Peptides Consumption by Application (2015-2020) (Mg)
Table 44. APAC Antimicrobial Peptides Consumption Market Share by Application (2015-2020)
Table 45. Europe Antimicrobial Peptides Consumption by Countries (2015-2020) (Mg)
Table 46. Europe Antimicrobial Peptides Consumption Market Share by Countries (2015-2020)
Table 47. Europe Antimicrobial Peptides Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Antimicrobial Peptides Value Market Share by Countries (2015-2020)
Table 49. Europe Antimicrobial Peptides Consumption by Type (2015-2020) (Mg)
Table 50. Europe Antimicrobial Peptides Consumption Market Share by Type (2015-2020)
Table 51. Europe Antimicrobial Peptides Consumption by Application (2015-2020) (Mg)
Table 52. Europe Antimicrobial Peptides Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Antimicrobial Peptides Consumption by Countries (2015-2020) (Mg)
Table 54. Middle East & Africa Antimicrobial Peptides Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Antimicrobial Peptides Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Antimicrobial Peptides Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Antimicrobial Peptides Consumption by Type (2015-2020) (Mg)
Table 58. Middle East & Africa Antimicrobial Peptides Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Antimicrobial Peptides Consumption by Application (2015-2020) (Mg)
Table 60. Middle East & Africa Antimicrobial Peptides Consumption Market Share by Application (2015-2020)
Table 61. Antimicrobial Peptides Distributors List
Table 62. Antimicrobial Peptides Customer List
Table 63. Global Antimicrobial Peptides Consumption Forecast by Countries (2021-2025) (Mg)
Table 64. Global Antimicrobial Peptides Consumption Market Forecast by Regions
Table 65. Global Antimicrobial Peptides Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Antimicrobial Peptides Value Market Share Forecast by Regions
Table 67. Global Antimicrobial Peptides Consumption Forecast by Type (2021-2025) (Mg)
Table 68. Global Antimicrobial Peptides Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Antimicrobial Peptides Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Antimicrobial Peptides Value Market Share Forecast by Type (2021-2025)
Table 71. Global Antimicrobial Peptides Consumption Forecast by Application (2021-2025) (Mg)
Table 72. Global Antimicrobial Peptides Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Antimicrobial Peptides Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Antimicrobial Peptides Value Market Share Forecast by Application (2021-2025)
Table 75. AnaSpec Product Offered
Table 76. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (USD/Mg) and Gross Margin (2018-2020E)
Table 77. AnaSpec Main Business
Table 78. AnaSpec Latest Developments
Table 79. AnaSpec Basic Information, Company Total Revenue (in $ million), Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 80. Ruixing Biotechnology Product Offered
Table 81. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (USD/Mg) and Gross Margin (2018-2020E)
Table 82. Ruixing Biotechnology Main Business
Table 83. Ruixing Biotechnology Latest Developments
Table 84. Ruixing Biotechnology Basic Information, Company Total Revenue (in $ million), Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 85. AMP Biotech Product Offered
Table 86. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (USD/Mg) and Gross Margin (2018-2020E)
Table 87. AMP Biotech Main Business
Table 88. AMP Biotech Latest Developments
Table 89. AMP Biotech Basic Information, Company Total Revenue (in $ million), Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 90. Novabiotics Product Offered
Table 91. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (USD/Mg) and Gross Margin (2018-2020E)
Table 92. Novabiotics Main Business
Table 93. Novabiotics Latest Developments
Table 94. Novabiotics Basic Information, Company Total Revenue (in $ million), Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 95. Chinese Peptide Product Offered
Table 96. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (USD/Mg) and Gross Margin (2018-2020E)
Table 97. Chinese Peptide Main Business
Table 98. Chinese Peptide Latest Developments
Table 99. Chinese Peptide Basic Information, Company Total Revenue (in $ million), Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 100. Phoenix Biotech Product Offered
Table 101. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (USD/Mg) and Gross Margin (2018-2020E)
Table 102. Phoenix Biotech Main Business
Table 103. Phoenix Biotech Latest Developments
Table 104. Phoenix Biotech Basic Information, Company Total Revenue (in $ million), Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 105. Hycult Biotech Product Offered
Table 106. Hycult Biotech Basic Information, Company Total Revenue (in $ million), Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 107. Hycult Biotech Main Business
Table 108. Hycult Biotech Latest Developments
Table 109. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (USD/Mg) and Gross Margin (2018-2020E)
Table 110. Ontores Product Offered
Table 111. Ontores Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (USD/Mg) and Gross Margin (2018-2020E)
Table 112. Ontores Main Business
Table 113. Ontores Latest Developments
Table 114. Ontores Basic Information, Company Total Revenue (in $ million), Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 115. Sunsmile Product Offered
Table 116. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (USD/Mg) and Gross Margin (2018-2020E)
Table 117. Sunsmile Main Business
Table 118. Sunsmile Latest Developments
Table 119. Sunsmile Basic Information, Company Total Revenue (in $ million), Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 120. GenScript Product Offered
Table 121. GenScript Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (USD/Mg) and Gross Margin (2018-2020E)
Table 122. GenScript Main Business
Table 123. GenScript Latest Developments
Table 124. GenScript Basic Information, Company Total Revenue (in $ million), Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 125. Zhongnong Yingtai Biotechnology Product Offered
Table 126. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (USD/Mg) and Gross Margin (2018-2020E)
Table 127. Zhongnong Yingtai Biotechnology Main Business
Table 128. Zhongnong Yingtai Biotechnology Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Zhongnong Yingtai Biotechnology Latest Developments
Table 130. Glam Technology Product Offered
Table 131. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (USD/Mg) and Gross Margin (2018-2020E)
Table 132. Glam Technology Main Business
Table 133. Glam Technology Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 134. Glam Technology Latest Developments
List of Figures
Figure 1. Picture of Antimicrobial Peptides
Figure 2. Antimicrobial Peptides Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Antimicrobial Peptides Consumption Growth Rate 2015-2025 (Mg)
Figure 5. Global Antimicrobial Peptides Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Plant Antimicrobial Peptides
Figure 7. Product Picture of Bacterial Antimicrobial Peptides
Figure 8. Product Picture of Animal Antimicrobial Peptides
Figure 9. Global Antimicrobial Peptides Consumption Market Share by Type (2015-2020)
Figure 10. Global Antimicrobial Peptides Value Market Share by Type (2015-2020)
Figure 11. Antimicrobial Peptides Consumed in Pharmaceuticals
Figure 12. Global Antimicrobial Peptides Market: Pharmaceuticals (2015-2020) (Mg)
Figure 13. Global Antimicrobial Peptides Market: Pharmaceuticals (2015-2020) ($ Millions)
Figure 14. Antimicrobial Peptides Consumed in Feed Additives
Figure 15. Global Antimicrobial Peptides Market: Feed Additives (2015-2020) (Mg)
Figure 16. Global Antimicrobial Peptides Market: Feed Additives (2015-2020) ($ Millions)
Figure 17. Antimicrobial Peptides Consumed in Others
Figure 18. Global Antimicrobial Peptides Market: Others (2015-2020) (Mg)
Figure 19. Global Antimicrobial Peptides Market: Others (2015-2020) ($ Millions)
Figure 20. Global Antimicrobial Peptides Consumption Market Share by Application (2015-2020)
Figure 21. Global Antimicrobial Peptides Value Market Share by Application (2015-2020)
Figure 22. Global Antimicrobial Peptides Sales Market Share by Company in 2017
Figure 23. Global Antimicrobial Peptides Sales Market Share by Company in 2019
Figure 24. Global Antimicrobial Peptides Revenue Market Share by Company in 2017
Figure 25. Global Antimicrobial Peptides Revenue Market Share by Company in 2019
Figure 26. Global Antimicrobial Peptides Sale Price by Company in 2019
Figure 27. Global Antimicrobial Peptides Consumption Market Share by Regions 2015-2020
Figure 28. Global Antimicrobial Peptides Value Market Share by Regions 2015-2020
Figure 29. Americas Antimicrobial Peptides Consumption 2015-2020 (Mg)
Figure 30. Americas Antimicrobial Peptides Value 2015-2020 ($ Millions)
Figure 31. APAC Antimicrobial Peptides Consumption 2015-2020 (Mg)
Figure 32. APAC Antimicrobial Peptides Value 2015-2020 ($ Millions)
Figure 33. Europe Antimicrobial Peptides Consumption 2015-2020 (Mg)
Figure 34. Europe Antimicrobial Peptides Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Antimicrobial Peptides Consumption 2015-2020 (Mg)
Figure 36. Middle East & Africa Antimicrobial Peptides Value 2015-2020 ($ Millions)
Figure 37. Americas Antimicrobial Peptides Consumption Market Share by Countries in 2019
Figure 38. Americas Antimicrobial Peptides Value Market Share by Countries in 2019
Figure 39. Americas Antimicrobial Peptides Consumption Market Share by Type in 2019
Figure 40. Americas Antimicrobial Peptides Consumption Market Share by Application in 2019
Figure 41. United States Antimicrobial Peptides Consumption Growth 2015-2020 (Mg)
Figure 42. United States Antimicrobial Peptides Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Antimicrobial Peptides Consumption Growth 2015-2020 (Mg)
Figure 44. Canada Antimicrobial Peptides Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Antimicrobial Peptides Consumption Growth 2015-2020 (Mg)
Figure 46. Mexico Antimicrobial Peptides Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Antimicrobial Peptides Consumption Market Share by Countries in 2019
Figure 48. APAC Antimicrobial Peptides Value Market Share by Regions in 2019
Figure 49. APAC Antimicrobial Peptides Consumption Market Share by Type in 2019
Figure 50. APAC Antimicrobial Peptides Consumption Market Share by Application in 2019
Figure 51. China Antimicrobial Peptides Consumption Growth 2015-2020 (Mg)
Figure 52. China Antimicrobial Peptides Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Antimicrobial Peptides Consumption Growth 2015-2020 (Mg)
Figure 54. Japan Antimicrobial Peptides Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Antimicrobial Peptides Consumption Growth 2015-2020 (Mg)
Figure 56. Korea Antimicrobial Peptides Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Antimicrobial Peptides Consumption Growth 2015-2020 (Mg)
Figure 58. Southeast Asia Antimicrobial Peptides Value Growth 2015-2020 ($ Millions)
Figure 59. India Antimicrobial Peptides Consumption Growth 2015-2020 (Mg)
Figure 60. India Antimicrobial Peptides Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Antimicrobial Peptides Consumption Growth 2015-2020 (Mg)
Figure 62. Australia Antimicrobial Peptides Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Antimicrobial Peptides Consumption Market Share by Countries in 2019
Figure 64. Europe Antimicrobial Peptides Value Market Share by Countries in 2019
Figure 65. Europe Antimicrobial Peptides Consumption Market Share by Type in 2019
Figure 66. Europe Antimicrobial Peptides Consumption Market Share by Application in 2019
Figure 67. Germany Antimicrobial Peptides Consumption Growth 2015-2020 (Mg)
Figure 68. Germany Antimicrobial Peptides Value Growth 2015-2020 ($ Millions)
Figure 69. France Antimicrobial Peptides Consumption Growth 2015-2020 (Mg)
Figure 70. France Antimicrobial Peptides Value Growth 2015-2020 ($ Millions)
Figure 71. UK Antimicrobial Peptides Consumption Growth 2015-2020 (Mg)
Figure 72. UK Antimicrobial Peptides Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Antimicrobial Peptides Consumption Growth 2015-2020 (Mg)
Figure 74. Italy Antimicrobial Peptides Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Antimicrobial Peptides Consumption Growth 2015-2020 (Mg)
Figure 76. Russia Antimicrobial Peptides Value Growth 2015-2020 ($ Millions)
Figure 77. Spain Antimicrobial Peptides Consumption Growth 2015-2020 (Mg)
Figure 78. Spain Antimicrobial Peptides Value Growth 2015-2020 ($ Millions)
Figure 79. Middle East & Africa Antimicrobial Peptides Consumption Market Share by Countries in 2019
Figure 80. Middle East & Africa Antimicrobial Peptides Value Market Share by Countries in 2019
Figure 81. Middle East & Africa Antimicrobial Peptides Consumption Market Share by Type in 2019
Figure 82. Middle East & Africa Antimicrobial Peptides Consumption Market Share by Application in 2019
Figure 83. Egypt Antimicrobial Peptides Consumption Growth 2015-2020 (Mg)
Figure 84. Egypt Antimicrobial Peptides Value Growth 2015-2020 ($ Millions)
Figure 85. South Africa Antimicrobial Peptides Consumption Growth 2015-2020 (Mg)
Figure 86. South Africa Antimicrobial Peptides Value Growth 2015-2020 ($ Millions)
Figure 87. Israel Antimicrobial Peptides Consumption Growth 2015-2020 (Mg)
Figure 88. Israel Antimicrobial Peptides Value Growth 2015-2020 ($ Millions)
Figure 89. Turkey Antimicrobial Peptides Consumption Growth 2015-2020 (Mg)
Figure 90. Turkey Antimicrobial Peptides Value Growth 2015-2020 ($ Millions)
Figure 91. GCC Countries Antimicrobial Peptides Consumption Growth 2015-2020 (Mg)
Figure 92. GCC Countries Antimicrobial Peptides Value Growth 2015-2020 ($ Millions)
Figure 93. Global Antimicrobial Peptides Consumption Growth Rate Forecast (2021-2025) (Mg)
Figure 94. Global Antimicrobial Peptides Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 95. Americas Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 96. Americas Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 97. APAC Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 98. APAC Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 99. Europe Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 100. Europe Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 101. Middle East & Africa Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 102. Middle East & Africa Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 103. United States Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 104. United States Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 105. Canada Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 106. Canada Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 107. Mexico Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 108. Mexico Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 109. Brazil Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 110. Brazil Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 111. China Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 112. China Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 113. Japan Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 114. Japan Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 115. Korea Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 116. Korea Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 117. Southeast Asia Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 118. Southeast Asia Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 119. India Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 120. India Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 121. Australia Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 122. Australia Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 123. Germany Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 124. Germany Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 125. France Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 126. France Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 127. UK Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 128. UK Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 129. Italy Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 130. Italy Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 131. Russia Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 132. Russia Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 133. Spain Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 134. Spain Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 135. Egypt Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 136. Egypt Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 137. South Africa Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 138. South Africa Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 139. Israel Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 140. Israel Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 141. Turkey Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 142. Turkey Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 143. GCC Countries Antimicrobial Peptides Consumption 2021-2025 (Mg)
Figure 144. GCC Countries Antimicrobial Peptides Value 2021-2025 ($ Millions)
Figure 145. AnaSpec Antimicrobial Peptides Market Share (2018-2020)
Figure 146. Ruixing Biotechnology Antimicrobial Peptides Market Share (2018-2020)
Figure 147. AMP Biotech Antimicrobial Peptides Market Share (2018-2020)
Figure 148. Novabiotics Antimicrobial Peptides Market Share (2018-2020)
Figure 149. Chinese Peptide Antimicrobial Peptides Market Share (2018-2020)
Figure 150. Phoenix Biotech Antimicrobial Peptides Market Share (2018-2020)
Figure 151. Hycult Biotech Antimicrobial Peptides Market Share (2018-2020)
Figure 152. Ontores Antimicrobial Peptides Market Share (2018-2020)
Figure 153. Sunsmile Antimicrobial Peptides Market Share (2018-2020)
Figure 154. GenScript Antimicrobial Peptides Market Share (2018-2020)
Figure 155. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Market Share (2018-2020)
Figure 156. Glam Technology Antimicrobial Peptides Market Share (2018-2020)


★調査レポート[世界の抗菌ペプチド市場予測 2020年-2025年] (コード:LPI20AP5947)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の抗菌ペプチド市場予測 2020年-2025年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆